TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9429331

Group type: EXPERIMENTAL
Intervention: Forced-air convective warming device used for at least 2 hours after the operation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hypothermic control group
Number of subjects: 0
Study: 8389662

Group type: EXPERIMENTAL
Intervention: ZCE-025
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: IMMU-4
Number of subjects: 32
Study: 3122381

Group type: EXPERIMENTAL
Intervention: Mannitol 20% (250 ml) with moderate hydration (2.5 L)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Hydration without mannitol
Number of subjects: 99
Study: 29876844

Group type: EXPERIMENTAL
Intervention: Short-term fasting (36 hours)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: High fat diet (HFD)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Overnight fast (control)
Number of subjects: 9
Study: 28122542

Group type: EXPERIMENTAL
Intervention: Conditional follow-up visit (return for follow-up only if signs have not resolved)
Number of subjects: 4300

Group type: COMPARATOR
Intervention: Universal follow-up visit (return for follow-up regardless of illness resolution)
Number of subjects: 4300
Study: 26183420

Group type: EXPERIMENTAL
Intervention: Preoperative respiratory rehabilitation (PR) for more than 7 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: No preoperative respiratory rehabilitation (NPR)
Number of subjects: 60
Study: 23277304

Group type: EXPERIMENTAL
Intervention: Social learning and cognitive behavioral therapy
Number of subjects: 200

Group type: COMPARATOR
Intervention: Education and support intervention
Number of subjects: 200
Study: 21450262

Group type: EXPERIMENTAL
Intervention: Imagining a best possible self (BPS) for 5 minutes per day over two weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Imagining daily activities (DA) for 5 minutes per day over two weeks
Number of subjects: 0
Study: 18974717

Group type: EXPERIMENTAL
Intervention: Caffeine (CAF) 6 mg.kg(‐1) body mass
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Caffeine (CAF)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (Pl)
Number of subjects: 8
Study: 16816222

Group type: EXPERIMENTAL
Intervention: Oxcarbazepine (mean dose=1515 mg/day)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Oxcarbazepine
Number of subjects: 116
Study: 12960189

Group type: EXPERIMENTAL
Intervention: (18)F-FDG brain PET scans in postlingually deaf patients
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Correlation of glucose metabolism with duration of deafness in postlingually deaf patients
Number of subjects: 9

Group type: COMPARATOR
Intervention: Healthy control subjects (age- and sex-matched)
Number of subjects: 9
Study: 10596684

Group type: EXPERIMENTAL
Intervention: Bradykinin inhalation
Number of subjects: 21

Group type: COMPARATOR
Intervention: Inhaled L‐ASA (90 mg/mL, 4 mL)
Number of subjects: 21
Study: 8537687

Group type: EXPERIMENTAL
Intervention: Pneumococcal glycoprotein conjugate vaccine (serotypes 6B, 14, 18C, 19F, and 23F linked to CRM197)
Number of subjects: 282

Group type: COMPARATOR
Intervention: 23-valent pneumococcal polysaccharide vaccine
Number of subjects: 282
Study: 1669628

Group type: EXPERIMENTAL
Intervention: Acupuncture as an adjuvant to neuroleptanalgesia (NLA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Neuroleptanalgesia (NLA) alone
Number of subjects: 40
Study: 6607696

Group type: EXPERIMENTAL
Intervention: Cimetidine (used until the night before the operation)
Number of subjects: 145

Group type: COMPARATOR
Intervention: No cimetidine (not receiving cimetidine in the weeks before operation)
Number of subjects: 145
Study: 31725692

Group type: EXPERIMENTAL
Intervention: Preoperative acetaminophen and carbohydrate drinks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard preoperative care (Control)
Number of subjects: 100
Study: 30626285

Group type: EXPERIMENTAL
Intervention: Transdermal glyceryl trinitrate (GTN) for 7 days
Number of subjects: 4011

Group type: COMPARATOR
Intervention: No GTN (control)
Number of subjects: 4011
Study: 28251606

Group type: EXPERIMENTAL
Intervention: Peri-operative continuous positive airway pressure (CPAP)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 135
Study: 24910161

Group type: EXPERIMENTAL
Intervention: Burping
Number of subjects: 71

Group type: COMPARATOR
Intervention: No-burping (Control)
Number of subjects: 71
Study: 24369008

Group type: EXPERIMENTAL
Intervention: Coach-led group intervention
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Self-directed individual intervention
Number of subjects: 241

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 241
Study: 22167079

Group type: EXPERIMENTAL
Intervention: Vaccination with Improvac (2 ml s. c.); administered at 12 weeks and 18 weeks
Number of subjects: 396

Group type: COMPARATOR
Intervention: Surgical castration
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Vaccination with Improvac
Number of subjects: 396
Study: 20020791

Group type: EXPERIMENTAL
Intervention: Local anesthetic + intravenous ketorolac tromethamine
Number of subjects: 27

Group type: COMPARATOR
Intervention: Intravenous ketorolac tromethamine alone
Number of subjects: 27
Study: 17093067

Group type: EXPERIMENTAL
Intervention: RSG+SPIRO
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: RSG+HCTZ
Number of subjects: 260

Group type: COMPARATOR
Intervention: RSG-C
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: RSG+FRUS
Number of subjects: 260
Study: 15068574

Group type: EXPERIMENTAL
Intervention: Tailored, nurse-administered smoking cessation intervention with telephone counseling
Number of subjects: 56
Study: 12033074

Group type: EXPERIMENTAL
Intervention: Cup-feeding (CF)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Bottle-feeding (BF)
Number of subjects: 78
Study: 9701406

Group type: EXPERIMENTAL
Intervention: 500 microg x m(‐3) NO2 for 30 min
Number of subjects: 16

Group type: COMPARATOR
Intervention: Purified air
Number of subjects: 16
Study: 7768259

Group type: EXPERIMENTAL
Intervention: Subcutaneous sumatriptan (16 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral sumatriptan (up to 400 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subcutaneous sumatriptan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral sumatriptan
Number of subjects: 0
Study: 2138237

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic peptide (ANP) 0.02 micrograms/kg.min i.v.
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Amiloride
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Aldosterone
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: ANP with Amiloride
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: ANP
Number of subjects: 6
Study: 373358

Group type: EXPERIMENTAL
Intervention: Fenfluramine therapy
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 38
Study: 6404954

Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg three times a day
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Diazepam 5 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 29843899

Group type: EXPERIMENTAL
Intervention: Stereotactic body radiation therapy (SBRT) 24 Gy
Number of subjects: 55

Group type: COMPARATOR
Intervention: Three-dimensional conformal radiotherapy (3DCRT) 30 Gy in 10 fractions
Number of subjects: 55
Study: 27590568

Group type: EXPERIMENTAL
Intervention: Hysteroscopic morcellation with the TRUCLEAR 8.0 Tissue Removal System
Number of subjects: 86

Group type: COMPARATOR
Intervention: Loop resection with a rigid 8.5‐mm bipolar resectoscope
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Hysteroscopic morcellation
Number of subjects: 86

Group type: COMPARATOR
Intervention: Loop resection
Number of subjects: 86
Study: 25193531

Group type: EXPERIMENTAL
Intervention: Gla‐300 (insulin glargine 300 units/mL)
Number of subjects: 811

Group type: COMPARATOR
Intervention: Gla‐100 (insulin glargine 100 units/mL)
Number of subjects: 811

Group type: EXPERIMENTAL
Intervention: Gla‐300
Number of subjects: 811
Study: 22476616

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Sulfonylureas
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Glucosidase inhibitors
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Glinides
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Glitazones
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: DPP-4 inhibitors
Number of subjects: 370

Group type: COMPARATOR
Intervention: Hypoglycaemia
Number of subjects: 370

Group type: COMPARATOR
Intervention: Thiazolidinediones
Number of subjects: 370
Study: 19683414

Group type: EXPERIMENTAL
Intervention: Shoulder Pain and Disability Index (SPADI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Croft Index
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Disabilities of the Arm, Shoulder, and Hand (DASH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visual Analog Scale for pain
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Health Assessment Questionnaire
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Problem-elicitation technique
Number of subjects: 0
Study: 18243498

Group type: EXPERIMENTAL
Intervention: 24 months adjuvant goserelin
Number of subjects: 1554

Group type: COMPARATOR
Intervention: 4 months goserelin followed by no additional therapy
Number of subjects: 1554
Study: 15683433

Group type: EXPERIMENTAL
Intervention: Nizatidine 150 mg b.i.d.
Number of subjects: 72

Group type: COMPARATOR
Intervention: Famotidine 20 mg b.i.d.
Number of subjects: 72
Study: 12458242

Group type: EXPERIMENTAL
Intervention: Off-pump technique
Number of subjects: 60

Group type: COMPARATOR
Intervention: On-pump technique
Number of subjects: 60
Study: 10621921

Group type: EXPERIMENTAL
Intervention: Sodium alginate (Gaviscon Advance)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 7733122

Group type: EXPERIMENTAL
Intervention: Acarbose 200 mg
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Tolbutamide 250 to 1,000 mg
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Acarbose-plus-tolbutamide
Number of subjects: 290

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 290
Study: 1914055

Group type: EXPERIMENTAL
Intervention: 10 mg nalbuphine after lidocaine anaesthesia
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 20 mg nalbuphine after lidocaine anaesthesia
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 30 mg nalbuphine after lidocaine anaesthesia
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 10 mg nalbuphine after 2-chloroprocaine anaesthesia
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 20 mg nalbuphine after 2-chloroprocaine anaesthesia
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 30 mg nalbuphine after 2-chloroprocaine anaesthesia
Number of subjects: 58

Group type: COMPARATOR
Intervention: lidocaine anaesthesia
Number of subjects: 58
Study: 7327976

Group type: EXPERIMENTAL
Intervention: Training at 1.68 rad . s‐1
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Training at 4.19 rad . s‐1
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (group A)
Number of subjects: 17
Study: 31283920

Group type: EXPERIMENTAL
Intervention: Low-dose CT screening (LDCT)
Number of subjects: 24453

Group type: EXPERIMENTAL
Intervention: Low-dose CT screening (LDCT) in patients with COPD
Number of subjects: 24453
Study: 29095274

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Vacuum erectile device (VED)
Number of subjects: 60
Study: 25694056

Group type: EXPERIMENTAL
Intervention: Candesartan (16 mg to 32 mg per day) in addition to routine standard of care
Number of subjects: 69

Group type: COMPARATOR
Intervention: Routine standard of care other than ARBs or ACEIs
Number of subjects: 69
Study: 24399285

Group type: EXPERIMENTAL
Intervention: Intensified aftercare (IG) following inpatient medical rehabilitation
Number of subjects: 422

Group type: COMPARATOR
Intervention: Usual care (CG) following inpatient medical rehabilitation
Number of subjects: 422
Study: 22074866

Group type: EXPERIMENTAL
Intervention: Immediate loading (IML) implants
Number of subjects: 12

Group type: COMPARATOR
Intervention: Conventional loading implants
Number of subjects: 12
Study: 19444561

Group type: EXPERIMENTAL
Intervention: Oral rehydration therapy (1000 ml of oral rehydration solution)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intravenous therapy (1000 ml of intravenous electrolyte solution)
Number of subjects: 50
Study: 17314338

Group type: EXPERIMENTAL
Intervention: Valacyclovir (500 mg twice daily)
Number of subjects: 136
Study: 15198290

Group type: EXPERIMENTAL
Intervention: Growth hormone (Genotropin, 1 mg/m2/day)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 25
Study: 11438316

Group type: EXPERIMENTAL
Intervention: Testosterone lozenge (1 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Testosterone gel (1 mg)
Number of subjects: 10
Study: 9593146

Group type: EXPERIMENTAL
Intervention: Clarithromycin 500 mg orally every 12 h for 10 days
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Loratadine 10 mg orally every 24 h for 10 days
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combination of clarithromycin and loratadine
Number of subjects: 24

Group type: COMPARATOR
Intervention: All three regimens (clarithromycin, loratadine, combination)
Number of subjects: 24
Study: 7874080

Group type: EXPERIMENTAL
Intervention: Interferon-alpha (IFN) 3-5 million units per day for 3 months
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Thymomodulin 10 mg three times per week for 2 months
Number of subjects: 180

Group type: COMPARATOR
Intervention: Conventional therapy alone
Number of subjects: 180
Study: 2896957

Group type: EXPERIMENTAL
Intervention: Treatment combined with fortnightly chemoprophylaxis with 'Maloprim' (pyrimethamine/dapsone)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment of presumptive episodes of clinical malaria with chloroquine
Number of subjects: 0
Study: 31296525

Group type: EXPERIMENTAL
Intervention: 70 kV protocol for CT angiography
Number of subjects: 90

Group type: COMPARATOR
Intervention: Automated tube voltage adaptation
Number of subjects: 90
Study: 28097310

Group type: EXPERIMENTAL
Intervention: IVT and MT
Number of subjects: 291

Group type: COMPARATOR
Intervention: MT
Number of subjects: 291
Study: 25572706

Group type: EXPERIMENTAL
Intervention: Baclofen 50 mg/day
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 23991838

Group type: EXPERIMENTAL
Intervention: Early BCG vaccination
Number of subjects: 281

Group type: COMPARATOR
Intervention: Delayed BCG vaccination
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: BCG vaccination with scar
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation with simultaneous BCG
Number of subjects: 281
Study: 21813807

Group type: EXPERIMENTAL
Intervention: GSTM1-0 genotype
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: GSTT1-0 genotype
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: GSTM1-0/GSTT1-0 (n = 37)
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Carotenoids and α- and γ-tocopherols
Number of subjects: 383
Study: 19433149

Group type: EXPERIMENTAL
Intervention: Experiential self-focus (concrete, process-focused)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Analytical self-focus (abstract, evaluative)
Number of subjects: 82
Study: 16679630

Group type: EXPERIMENTAL
Intervention: Intravenous L-carnitine 20 mg/kg after every dialysis session for 8 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo after every dialysis session for 8 weeks
Number of subjects: 20
Study: 15090626

Group type: COMPARATOR
Intervention: Placebo (3 g of high oleic acid sunflower oil)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: 1.5 g of cis‐9,trans‐11 (c9t11) CLA
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: 3 g of cis‐9,trans‐11 (c9t11) CLA
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: 1.5 g of trans‐10,cis‐12 (t10c12) CLA
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: 3 g of trans‐10,cis‐12 (t10c12) CLA
Number of subjects: 81
Study: 10856731

Group type: EXPERIMENTAL
Intervention: Metoprolol (mean final dosage 135 mg/day)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 9355892

Group type: EXPERIMENTAL
Intervention: Vitamin E (200 mg TID)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 8471413

Group type: EXPERIMENTAL
Intervention: Cimetidine (400 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ranitidine (150 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cimetidine and Ranitidine
Number of subjects: 12
Study: 3890036

Group type: EXPERIMENTAL
Intervention: Mepivacaine carbonate (1% solution)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Mepivacaine hydrochloride (1% solution)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Mepivacaine carbonate
Number of subjects: 40

Group type: COMPARATOR
Intervention: Mepivacaine hydrochloride
Number of subjects: 40
Study: 31324175

Group type: EXPERIMENTAL
Intervention: Financial micro-incentive (food voucher)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Male-targeted HIV specific decision support (EPIC-HIV)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both micro-incentives and male-targeted decision support
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 45
Study: 28391756

Group type: EXPERIMENTAL
Intervention: Sanger sequencing and minisequencing
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Length heteroplasmy (LH)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Point mutation heteroplasmy (PMH)
Number of subjects: 166
Study: 25865740

Group type: EXPERIMENTAL
Intervention: Audiovisual preconditioning (video with pre-recorded commentary)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no audiovisual preconditioning)
Number of subjects: 0
Study: 23643011

Group type: EXPERIMENTAL
Intervention: Cookgas intubating laryngeal airway (CILA)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Fastrach intubating laryngeal mask airway (FT‐LMA)
Number of subjects: 86

Group type: COMPARATOR
Intervention: FT‐LMA
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: CILA and FT‐LMA
Number of subjects: 86
Study: 21247967

Group type: EXPERIMENTAL
Intervention: Vincristine-doxorubicin-dexamethasone
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Melphalan-prednisolone
Number of subjects: 33
Study: 20306937

Group type: EXPERIMENTAL
Intervention: Involvement of hospital chaplains in spiritual care during treatment.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care without chaplain involvement.
Number of subjects: 0
Study: 17761574

Group type: EXPERIMENTAL
Intervention: Exposure to acts of terrorism
Number of subjects: 960

Group type: COMPARATOR
Intervention: Posttraumatic stress and depressive symptoms (controlled for)
Number of subjects: 960
Study: 15066900

Group type: EXPERIMENTAL
Intervention: Transplant
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham Surgery
Number of subjects: 30
Study: 11223765

Group type: EXPERIMENTAL
Intervention: Computer-based intervention (prevention group)
Number of subjects: 542

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 542
Study: 7921428

Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 3045099

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 60
Study: 31144057

Group type: EXPERIMENTAL
Intervention: Video group
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 91
Study: 28973430

Group type: EXPERIMENTAL
Intervention: Antecedent hypoglycemia (3 periods of 45 minutes at 2.8 mmol/L)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (3 periods of 45 minutes at 6 mmol/L)
Number of subjects: 10
Study: 25932792

Group type: EXPERIMENTAL
Intervention: ERN (2g/day)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Combo therapy (ERN + P-OM3)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: P-OM3 (4g/day)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 23548121

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture (EA) group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham electro-acupuncture (SA) group
Number of subjects: 0
Study: 21246465

Group type: EXPERIMENTAL
Intervention: Alarm-clock set at 2 h intervals for glucose self monitoring
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nurse performing blood glucose determinations
Number of subjects: 30

Group type: COMPARATOR
Intervention: Patients left undisturbed
Number of subjects: 30
Study: 18342395

Group type: EXPERIMENTAL
Intervention: Sensory education program with 12 sessions of taste lessons 'Les classes du goût' by J. Puisais
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (no sensory education)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Sensory education program
Number of subjects: 180
Study: 16861099

Group type: EXPERIMENTAL
Intervention: Sibutramine 10 mg QD
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 12963170

Group type: EXPERIMENTAL
Intervention: Oral-conjugated oestrogen 0.625 mg daily (n=13)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Transdermal oestrogen patches 50 microg daily (n=10)
Number of subjects: 23
Study: 10720589

Group type: EXPERIMENTAL
Intervention: Allopurinol (300 mg for 1 month)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 9418383

Group type: EXPERIMENTAL
Intervention: Younger adults
Number of subjects: 371

Group type: COMPARATOR
Intervention: Elderly adults
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Testimony from elderly witnesses (manipulated to appear as younger)
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Testimony from younger witnesses (manipulated to appear as older)
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Transcribed testimonies from Experiment 1 participants
Number of subjects: 371